Agilent Technologies stock firms ahead of earnings as guidance and analyst targets support the outlook
Published on 08/19/2026 at 17:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Agilent Technologies Inc. (ISIN US00846U1016) stock is trading close to recent highs ahead of its scheduled earnings release on August 19, 2026, with recent data showing the shares opening at $148.66 and a fair value indication around $155.31 as of August 19, 2026.
Current market data compiled on August 19, 2026 highlights that Agilent shares have been changing hands in the mid to upper $140 range on the New York Stock Exchange, with one valuation snapshot citing a $148.52 close on August 18, 2026 and another quote indicating a $148.79 close at 4:00 p.m. ET on the same date.
For investors, the setup going into the latest quarterly numbers combines a firm share price base, detailed guidance for fiscal 2026, and a consensus view that still sees upside from current levels.
Shares trade above recent averages
Recent quote data as of August 18, 2026 shows Agilent Technologies stock closing at $148.79 on the primary US venue at 4:00 p.m. ET, reflecting a 0.23 percent gain on the day and positioning the shares just above a $148.52 closing snapshot reported by another market-data overview for the same session.
A separate fair value indication published on August 19, 2026 points to a $155.31 reference price for Agilent, representing a 4.63 percent gain from the previous day and implying that the stock is trading noticeably above the $148.66 level cited as the opening price on August 19, 2026. This comparison underscores that the shares are now hovering between the high-$140s and mid-$150s, a range that investors will be watching closely as new earnings information arrives.
In addition, a euro-denominated quote from a European trading venue on August 19, 2026 shows Agilent at 127.45 EUR, with a five-day change of -0.66 percent but a year-to-date performance of 9.45 percent, signaling that the stock has delivered single-digit percentage appreciation since the start of 2026 even as short-term moves have been more muted.
Guidance and earnings expectations
Beyond the day-to-day trading, the latest reported quarterly figures and guidance give a clearer picture of Agilent’s operational momentum heading into the August 19, 2026 release. According to a recent earnings summary linked to the company’s May 27, 2026 quarter, Agilent posted earnings per share (EPS) of $1.49 for that period, beating the consensus estimate of $1.41 by $0.08, and generated revenue of $1.83 billion versus analyst expectations of $1.80 billion.
The same overview indicates that Agilent’s quarterly revenue was up 10.0 percent year-over-year, with the prior-year period delivering EPS of $1.31, so the latest $1.49 figure represents an EPS increase of $0.18 or roughly 13.7 percent compared with the same quarter in the previous year.
For the current fiscal year 2026, the company has issued guidance calling for full-year EPS in the range of $6.000 to $6.100, while its guidance for the third quarter of 2026 is set at $1.480 to $1.500 EPS. Research analysts tracking the stock anticipate that Agilent will post $6.03 EPS for fiscal 2026, a point estimate that sits close to the midpoint of management’s guided range and offers a concrete benchmark against which the upcoming quarterly result will be judged.
These guidance figures indicate that Agilent’s management expects the business to build on the strong May 27, 2026 quarter, with the Q3 2026 EPS range of $1.480 to $1.500 only modestly below the prior $1.49 print and the full-year EPS outlook framing a steady earnings trajectory through the remainder of the fiscal year.
Analyst consensus and valuation context
From a valuation perspective, various analyst and data overviews indicate that Agilent Technologies currently carries a consensus rating described as a moderate buy, supported by multiple buy or strong buy recommendations and only a minority of hold ratings.
One aggregated rating summary cites 15 buy or strong buy opinions and an average price target of $160.24, compared with the $148.66 share price reported as the opening level on August 19, 2026. The gap between the consensus target and the latest indicated price implies upside of $11.58 per share or around 7.8 percent, suggesting that the stock trades at a discount to the average analyst expectation.
Another institutional-holdings alert notes that the moderate buy view and the $160.24 average target are broadly consistent across different datasets, reinforcing the notion that the sell-side still expects further appreciation if Agilent can deliver on its stated guidance.
The combination of a share price in the high-$140s, a fair value indication above $155, and a consensus target above $160 places Agilent in a zone where valuation is supported by forward earnings projections yet still leaves room for potential re-rating, particularly if upcoming results show continued double-digit revenue growth and EPS expansion versus the prior year.
Options activity hints at volatility expectations
Options data for Agilent Technologies as of August 19, 2026 point to heightened interest in contracts tied to the company’s near-term moves. A dedicated options analysis highlights the September 18, 2026 $85.00 call as having one of the highest implied volatility readings among equity options observed on that date, suggesting that market participants are positioning for sizable swings in the stock over the coming month.
While the $85.00 strike sits well below the current share price in the $140s, the elevated implied volatility speaks to expectations that Agilent could experience pronounced price action around its earnings release and subsequent news flow, even if the absolute level of the underlying remains far above that strike.
For retail investors, such options signals can serve as a secondary gauge of sentiment and risk appetite, complementing the more traditional metrics like EPS guidance, revenue growth, and analyst price targets that frame the fundamental story.
Representative product: chromatography and mass spectrometry systems
Agilent Technologies is best known among laboratory customers for its portfolio of analytical instruments, including chromatography and mass spectrometry systems used in pharmaceutical development, environmental testing, and food safety monitoring. These systems typically combine high-performance hardware with software to separate, detect, and quantify complex mixtures of chemical compounds.
In practice, an Agilent liquid chromatography-mass spectrometry (LC-MS) platform might be deployed in a drug discovery lab to analyze metabolites or active pharmaceutical ingredients with high precision, helping scientists confirm purity, identify degradation products, and ensure that regulatory standards are met. Such applications tie directly into recurring demand from regulated industries, providing Agilent with a base of customers who require consistent, reliable measurement technology and related consumables.
This kind of product presence in mission-critical workflows helps underpin Agilent’s revenue streams and contributes to the earnings stability reflected in its 2026 guidance ranges, even as broader macroeconomic or market pressures may influence short-term trading in the stock.
Stock positioning ahead of the August 19, 2026 earnings release
As of the close on August 18, 2026 at 4:00 p.m. ET, Agilent Technologies stock was quoted at $148.79 on its primary US listing, with recent fair value indications pointing toward $155.31 on August 19, 2026 and consensus analyst targets centered near $160.24.
This constellation of figures means that going into the August 19, 2026 earnings report, the shares are trading below the average Wall Street target yet above recent closing snapshots, while guidance for fiscal 2026 calls for EPS between $6.000 and $6.100 and the most recent quarter delivered 10.0 percent year-over-year revenue growth to $1.83 billion.
For investors evaluating Agilent, the interplay between a firm earnings outlook, moderate upside versus consensus valuation, and signs of elevated options-implied volatility provides a quantified framework for assessing risk and potential reward ahead of the latest set of financial results.
Read more
Further recent coverage on Agilent Technologies stock
Fact box
Company: Agilent Technologies Inc.
ISIN: US00846U1016
Ticker: A
Exchange: NYSE
Price (as of August 18, 2026, 4:00 p.m. ET): $148.79 USD
Sector / Industry: Health care - medical research and laboratory instruments
Index membership: S&P 500
